Record-high rains left at least 33 dead, pile of cars on roads in China; China rejects WHO plan for another probe of COVID-19 origin; China considering foreign booster shot to improve efficacy of its vaccines

PTVPhilippines 2021-07-22

Views 11

Record-high rains left at least 33 dead, pile of cars on roads in China; China rejects WHO plan for another probe of COVID-19 origin; China considering foreign booster shot to improve efficacy of its vaccines
Show more

Share This Video


Download

  
Report form
RELATED VIDEOS
FDA, tiniyak na mabisa ang COVID-19 vaccines vs. bagong variants; efficacy ng ilan pang COVID-19 vaccines vs. Delta variant, patuloy na pinag-aaralan
play
02:42

FDA, tiniyak na mabisa ang COVID-19 vaccines vs. bagong variants; efficacy ng ilan pang COVID-19 vaccines vs. Delta variant, patuloy na pinag-aaralan
Pagbabakuna ng booster shot ng COVID-19 vaccines, pinag-aaralan na ng DOH; Health workers at immunocompromised individuals, prayoridad na mabigyan ng booster shot vs. COVID-19
play
02:32

Pagbabakuna ng booster shot ng COVID-19 vaccines, pinag-aaralan na ng DOH; Health workers at immunocompromised individuals, prayoridad na mabigyan ng booster shot vs. COVID-19
Booster shots sa healthcare workers at immunocompromised sa 4th quarter ng 2021, inaprubahan ng DOH; Pfizer vaccine, inirekomenda na booster shot sa mga nakatanggap ng AstraZeneca, Sinovac, at Moderna vaccines
play
02:54

Booster shots sa healthcare workers at immunocompromised sa 4th quarter ng 2021, inaprubahan ng DOH; Pfizer vaccine, inirekomenda na booster shot sa mga nakatanggap ng AstraZeneca, Sinovac, at Moderna vaccines
Pfizer COVID-19 vaccines na dumating sa bansa, sa edad 16 pataas pa lang umano pwedeng gamitin; Dr. Gloriani, tiwalang hindi gaanong bababa ang efficacy ng mga bakuna sa B.1.617 variant
play
02:48

Pfizer COVID-19 vaccines na dumating sa bansa, sa edad 16 pataas pa lang umano pwedeng gamitin; Dr. Gloriani, tiwalang hindi gaanong bababa ang efficacy ng mga bakuna sa B.1.617 variant
WHO: Efficacy ng COVID-19 vaccines vs. Delta variant, bumaba sa 40% kaya mahalaga pa rin ang health protocols
play
04:51

WHO: Efficacy ng COVID-19 vaccines vs. Delta variant, bumaba sa 40% kaya mahalaga pa rin ang health protocols
Laging Handa | COVID-19 vaccines, magkakaiba ang efficacy rates
play
14:41

Laging Handa | COVID-19 vaccines, magkakaiba ang efficacy rates
FDA, inaprubahan na ang paggamit ng Pfizer vaccines sa edad 12- 15 years old; Sinovac vaccines, pinapayagan na ring iturok sa mga kabataan sa China
play
12:01

FDA, inaprubahan na ang paggamit ng Pfizer vaccines sa edad 12- 15 years old; Sinovac vaccines, pinapayagan na ring iturok sa mga kabataan sa China
Pagbibigay ng bivalent COVID-19 vaccines bilang first o second booster, pinag-aaralan ng DOH
play
01:32

Pagbibigay ng bivalent COVID-19 vaccines bilang first o second booster, pinag-aaralan ng DOH
DOH: Ikatlong booster shot ng bivalent vaccines, maganda ang maidudulot sa katawan panlaban sa COVID-19
play
02:21

DOH: Ikatlong booster shot ng bivalent vaccines, maganda ang maidudulot sa katawan panlaban sa COVID-19
WHO recommends booster shots for immunocompromised individuals and senior citizens who received Sinovac or Sinopharm vaccines
play
01:57

WHO recommends booster shots for immunocompromised individuals and senior citizens who received Sinovac or Sinopharm vaccines
3-M doses ng Sinovac vaccines na dumating sa bansa, ilalaan sa booster shot ayon kay Sec. Galvez
play
02:39

3-M doses ng Sinovac vaccines na dumating sa bansa, ilalaan sa booster shot ayon kay Sec. Galvez
Cebu City LGU, muling nagpaalala na hindi pa pinahihintulutan ang booster shots ng COVID-19 vaccines
play
02:10

Cebu City LGU, muling nagpaalala na hindi pa pinahihintulutan ang booster shots ng COVID-19 vaccines